MacroGenics Provides Update on Corporate Progress and Third Quarter 2016 Financial Results

Go back to MacroGenics Provides Update on Corporate Progress and Third Quarter 2016 Financial Results

Macrogenics (MGNX) Misses Q3 EPS by 17c

November 2, 2016 4:22 PM EDT

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of ($0.97), $0.17 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $12.45 million.

Cash, cash equivalents and marketable securities as of September 30, 2016, were $314.1 million, compared to $339.0 million as of December 31,... More